Study Site 402 — Washington D.C., District of Columbia

Study Site 402 is a clinical research site located in Washington D.C., District of Columbia, United States.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 402 has participated in 1 clinical trials.

Therapeutic areas: Pruritus, Burns.

Sponsors: Vyne Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 402?

Study Site 402 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 402 conducted?

Study Site 402 has 1 clinical trials on record. Their work covers Pruritus, Burns.

Is Study Site 402 accredited by Crixeo Health?

Study Site 402 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 402?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.